bromouracil has been researched along with Breast Cancer in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kallos, J | 1 |
| Hollander, VP | 1 |
| Baskevitch, PP | 1 |
| Rochefort, H | 1 |
1 other study available for bromouracil and Breast Cancer
| Article | Year |
|---|---|
Study of the photoattachment of estrogen receptor to the nuclear acceptor sites in human breast cancer cells.
Topics: Breast Neoplasms; Bromouracil; Cell Nucleus; DNA, Neoplasm; Humans; Receptors, Estrogen; Ultraviolet | 1980 |